Barcelona, Spain (PRWEB) November 04, 2011
Imedex, LLC Presents: ESMO 14th World Congress on Gastrointestinal Cancer on June 27-30, 2012 in Barcelona, Spain. This oncology continuing medical education event will present a comprehensive overview of the latest advances and innovations in the gastrointestinal field.
The ESMO World Congress on Gastrointestinal Cancer is the world’s leading forum for practicing cancer research clinicians and specialists to stay abreast of the newest information and review forward-looking practices for the management of gastrointestinal cancer. Over 60 expert specialists will lead sessions and meet with participants in small targeted groups to address educational and practical advancements that are tailored to the needs of their audience. Among the specialists will be Nadir Arber, MD, MSc, MHA, Andrés Cervantes, MD, PhD, Fortunato Ciardiello, MD, PhD, Mario Dicato, MD, Bengt Glimelius, MD, PhD, Richard M. Goldberg, MD, Axel Grothey, MD, Karin Haustermans, MD, PhD, Yoon-Koo Kang, MD, PhD, David J. Kerr, MD, FRCP, Roberto Labianca, MD, John L. Marshall, MD, Bernard Nordlinger, MD, Arnaud D. Roth, MD, Philippe Rougier, MD, PhD, Wolff Schmiegel, MD, PhD, Josep Tabernero, MD, PhD, Eric Van Cutsem, MD, PhD, Cornelius J.H. van de Velde, MD, PhD and John R. Zalcberg, MD, PhD. The World Congress will focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms. A broad range of experts will be in attendance, including a target audience of practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers. Cutting-edge research will be at the core of this continuing medical education conference, and researchers and practitioners will be given the ability to interact with colleagues worldwide to share their best practices. Participants are strongly encouraged to submit their abstracts to be considered for presentation.
Upon completion of this continuing medical education conference, attendees should be able to:
- Identify and comment on current controversies in the management of patients with gastric or esophageal cancers
- Discuss contemporary treatment options for patients with gastric or esophageal cancers
- Specify available treatment options for rare gastrointestinal and neuroendocrine tumors
- Recognize the epidemiology and pathogenesis of hepatocellular carcinoma
- Deliberate the management of patients with cancer of the liver
- Understand adjuvant and neoadjuvant treatment options for patients with locally advanced and metastatic cancer of the pancreas
- Select the most appropriate detection, screening, and chemoprevention methods for colorectal cancer
- Generalize the use of molecular markers for screening and prognosis of colorectal cancer and gastric cancer
- Select the most appropriate adjuvant and neoadjuvant treatments for colorectal cancer patients
- Comment on and recognize new agents in the treatment of colorectal cancer and the latest clinical trials results
- Detect and adopt treatment strategies for rectal cancer
- Distinguish appropriate surgical techniques for the treatment of gastrointestinal cancers
This live gastroenteroogy CME webinar will be held on 27-30 June 2012.
For more information and to register for the ESMO 14th World Congress on Gastrointestinal Cancer on June 27-30, 2012 please contact us:
E-mail us at registration(at)imedex(dot)com
Call us at 1-512-583-8385
Register Online at http://www.worldgicancer.com
For event updates, and more information on this exciting oncology-cme event and to connect with us! Find us on:
Facebook at https://www.facebook.com/pages/World-Congress-on-Gastrointestinal-Cancer/238342882879815?sk=wall.
About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.®
Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.
Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.
Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.
To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.